An interventional study of Constant Heat Exposure and Progressively Increasing Heat Exposure in Body Temperature Changes, Heat Stress and Heat Exposure, sponsored by University of Ottawa. Recruiting at 1 site in Canada. Open to male participants aged 45 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by University of Ottawa · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Body Temperature Changes with a site in Canada — 6 open to participants now, 6 under way, none of them phase 3. Body Temperature Changes · Canada.
Among the 13 studies in Body Temperature Changes with a site in Canada, this one is the 5th largest by planned enrollment, is one of 5 that started in 2026, is one of 13 with no phase, and was the 13th registered.
97 studies on the registry are indexed under Body Temperature Changes; 20 are open to participants now.
Browse Body Temperature Changes studies →6 of the 13 studies in Body Temperature Changes with a site in Canada are open now. Recruiting first, the newest first:
University of Ottawa · Sites in Canada
Ages 9–25 · Healthy volunteers
University of Ottawa · Sites in Canada
Ages 50–75 · Men only · Healthy volunteers
University of Ottawa · Sites in Canada
Ages 18–70 · Healthy volunteers
University of Ottawa · Sites in Canada
Ages 18–35 · Women only · Healthy volunteers
University of Ottawa · Sites in Canada
Ages 9–25 · Women only · Healthy volunteers
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 12 Body Temperature Changes studies recruiting now, 3 (25%) set no upper age limit and 8 (67%) stop at 75 or younger; 3 take children under 18; 8 take healthy volunteers.
This study: 45 Years to 65 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 5 started in 2026.
This study's planned enrollment of 14 is below the median of 40 across 68 interventional studies indexed under Body Temperature Changes.
Median enrollment 12 across the 13 interventional studies. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 5 most frequent:
University of Ottawa is the lead sponsor of 125 studies on the registry; 31 are open to participants now.
University of Ottawa has 9 studies filed under Body Temperature Changes — fewer than ten, so there is no comparison to draw.
5 of the studies in Body Temperature Changes with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07664462University of OttawaWorking in the Heat at Simulated Altitude: Effects of Normobaric Hypoxia on Physiological Strain | 2026-12-31 |
| NCT07781592University of OttawaExercise Intensity and Heat Responses in Children and Youth | 2027-04-30 |
| NCT07781605University of OttawaAmbient Temperature and Thermoregulation During Exercise in Children and Youth | 2027-04-30 |
| NCT07847437University of OttawaProgressive Heat Exposure and Physiological Strain | 2027-06-30 |
| NCT07656519University of OttawaConsecutive Occupational Heat Exposure With and Without Overnight Cooling | 2027-06-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 13 studies in Body Temperature Changes with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Occupational heat-stress guidelines are commonly based on the level of environmental heat exposure and are largely derived from studies conducted under constant environmental conditions. However, outdoor workers are typically exposed to dynamic conditions, with environmental heat often increasing progressively from morning to afternoon. Consequently, workers may experience substantially different patterns of heat exposure across the workday even when average daily heat exposure is equivalent. It remains unclear whether the temporal pattern of heat exposure influences the amount of work that can be performed or the physiological strain experienced during a workday. Understanding these responses is important for determining whether occupational heat-stress guidelines developed under constant laboratory conditions adequately protect workers exposed to progressively changing environmental conditions.
The primary objective of this study is to determine whether the temporal pattern of heat exposure influences work performed and physiological heat strain during a simulated occupational workday in healthy middle-aged and older men. Participants will complete two 9-hour simulated workdays consisting of a 4-hour morning work period, a 1-hour lunch break, and a 4-hour afternoon work period. During one trial, wet-bulb globe temperature (WBGT) will remain constant at 28°C throughout the workday, whereas during the other trial, WBGT will progressively increase from morning to afternoon to simulate the changing environmental conditions of a typical hot summer workday. Both trials will have the same mean daily WBGT of 28°C. Participants will perform moderate-intensity treadmill exercise, and measures including total work performed, core temperature, heart rate, and time to the initial stay-time threshold will be assessed to determine whether constant and progressively increasing heat exposures produce different physiological and work-performance responses across the workday.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will complete a 9-hour simulated occupational workday consisting of a 4-hour morning work period, a 1-hour seated lunch-recovery period, and a 4-hour afternoon work period. Wet-bulb globe temperature (WBGT) will remain constant at 28°C throughout the workday. During each work period, participants will perform moderate-intensity treadmill walking at a metabolic heat production of approximately 200 W·m-2. Participants will initially work continuously until reaching the initial stay-time threshold, defined as a core temperature of 38.0°C or an increase of 1.0°C above pre-work baseline, whichever occurs first. Thereafter, participants will complete 45-min work and 15-min seated rest cycles for the remainder of the work period.
Other: Constant Heat Exposure
Participants will complete a 9-hour simulated occupational workday consisting of a 4-hour morning work period, a 1-hour seated lunch-recovery period, and a 4-hour afternoon work period. WBGT will progressively increase from morning to afternoon to simulate the changing environmental conditions of a hot summer workday, while maintaining a mean daily WBGT of 28°C. During each work period, participants will perform moderate-intensity treadmill walking at a metabolic heat production of approximately 200 W·m-2. Participants will initially work continuously until reaching the initial stay-time threshold, defined as a core temperature of 38.0°C or an increase of 1.0°C above pre-work baseline, whichever occurs first. Thereafter, participants will complete 45-min work and 15-min seated rest cycles for the remainder of the work period.
Other: Progressively Increasing Heat Exposure
Participants complete a simulated occupational workday under constant environmental conditions, with WBGT maintained at 28°C throughout the morning and afternoon work periods.
Participants complete a simulated occupational workday in which WBGT progressively increases from morning to afternoon while maintaining a mean daily WBGT of 28°C.
Total work performed
Total work completed during each 240-minute morning and afternoon work period, expressed as cumulative minutes of treadmill walking. Each work period consists of an initial continuous walking phase until core temperature reaches 38.0°C or increases by 1.0°C above the pre-work baseline, whichever occurs first, followed by intermittent 45-min work and 15-min seated rest cycles.
Time frame: From the start to the end of the morning and afternoon work periods during each experimental trial (0-4 hours and 5-9 hours after the start of the trial, respectively).
Initial stay time
Time, in minutes, from the start of continuous treadmill walking until the initial stay-time threshold is reached, defined as a core temperature of 38.0°C or an increase of 1.0°C above the pre-work baseline, whichever occurs first. Participants who do not reach the threshold during the 240-minute work period will be identified as not having reached the threshold within 240 min.
Time frame: During the initial continuous walking phase of each morning and afternoon work period.
Core temperature
Core temperature measured continuously using a rectal thermocouple temperature probe to assess thermoregulatory strain throughout the simulated workday.
Time frame: Continuously throughout each experimental trial, including the morning work period, lunch recovery, and afternoon work period.
Average core temperature during work-rest cycles
Average core temperature during the intermittent 45-min work and 15-min seated rest cycles following attainment of the initial stay-time threshold.
Time frame: During the work-rest cycles of each morning and afternoon work period.
Mean skin temperature
Mean skin temperature calculated from temperatures measured at eight body sites using ISO 9886 weighting factors.
Time frame: Assessed throughout each experimental trial, including the morning work period, lunch recovery, and afternoon work period.
Heart rate
Heart rate measured continuously using a chest-strap heart rate monitor and expressed as absolute heart rate.
Time frame: Continuously throughout each experimental trial, including the morning work period, lunch recovery, and afternoon work period.
Percentage of heart rate reserve
Heart rate expressed as a percentage of the participant's heart rate reserve to assess relative cardiovascular strain during heat exposure.
Time frame: Throughout each experimental trial, including the morning work period, lunch recovery, and afternoon work period.
Systolic blood pressure
Systolic blood pressure measured at the brachial artery using automated oscillometry. Three measurements obtained at approximately 1-min intervals will be averaged for analysis.
Time frame: Assessed at predetermined intervals throughout each experimental trial.
Diastolic blood pressure
Diastolic blood pressure measured at the brachial artery using automated oscillometry. Three measurements obtained at approximately 1-min intervals will be averaged for analysis.
Time frame: Assessed at predetermined intervals throughout each experimental trial.
Heart rate variability: standard deviation of normal R-R intervals (SDNN)
Cardiac autonomic modulation assessed from consecutive R-R intervals obtained using a 5-lead Holter electrocardiogram to calculate the standard deviation of normal R-R intervals (SDNN), expressed in milliseconds.
Time frame: Throughout each experimental trial.
Heart rate variability: root mean square of successive differences (RMSSD)
Cardiac autonomic modulation assessed from consecutive R-R intervals obtained using a 5-lead Holter electrocardiogram to calculate the root mean square of successive differences between adjacent normal R-R intervals (RMSSD), expressed in milliseconds.
Time frame: Throughout each experimental trial.
Urine specific gravity
Urine specific gravity measured to assess hydration status upon arrival at the laboratory. Higher values indicate greater urine concentration, whereas lower values indicate lower urine concentration.
Time frame: Assessed upon arrival before each experimental trial.
Fluid consumption
Cumulative fluid consumption determined from all fluid consumed during each experimental session.
Time frame: Throughout each experimental trial.
Fluid loss from body mass change
Fluid loss calculated from changes in body mass during each daytime work exposure, corrected for food and fluid intake.
Time frame: Assessed at the end of each 240-minute morning and afternoon work period of each experimental trial.
Thermal sensation
Thermal sensation assessed using an 8-point scale ranging from 0 (neutral) to 7 (extremely hot). Higher scores indicate a greater sensation of heat.
Time frame: Assessed at baseline, every 10 min during initial continuous work, at attainment of the initial stay-time threshold, at the end of the work and recovery components of each work-rest cycle, and at the beginning and end of lunch recovery.
Thermal comfort
Thermal comfort assessed using the ISO 10551 scale ranging from 1 (comfortable) to 4 (very uncomfortable). Higher scores indicate greater thermal discomfort.
Time frame: Assessed at baseline, every 10 min during initial continuous work, at attainment of the initial stay-time threshold, at the end of the work and recovery components of each work-rest cycle, and at the beginning and end of lunch recovery.
Thirst sensation
Thirst sensation assessed using a 9-point scale ranging from 1 (not thirsty at all) to 9 (very, very thirsty). Higher scores indicate greater perceived thirst
Time frame: Assessed at baseline, every 10 min during initial continuous work, at attainment of the initial stay-time threshold, at the end of the work and recovery components of each work-rest cycle, and at the beginning and end of lunch recovery.
Affective state
Affective state will be assessed using the 11-point Feeling Scale ranging from -5 (very bad) to +5 (very good), with 0 representing neutral. Higher scores indicate more positive affective state.
Time frame: Assessed at baseline, every 10 min during initial continuous work, at attainment of the initial stay-time threshold, at the end of the work and recovery components of each work-rest cycle, and at the beginning and end of lunch recovery.
Perceived arousal
Perceived arousal assessed using a 7-point scale ranging from 1 (low arousal) to 7 (high arousal). Higher scores indicate greater perceived arousal.
Time frame: Assessed at baseline, every 10 min during initial continuous work, at attainment of the initial stay-time threshold, at the end of the work and recovery components of each work-rest cycle, and at the beginning and end of lunch recovery.
Rating of perceived exertion
Perceived exertion assessed using the Borg Rating of Perceived Exertion scale ranging from 6 (no exertion at all) to 20 (maximal exertion). Higher scores indicate greater perceived exertion.
Time frame: Assessed at baseline, every 10 min during initial continuous work, at attainment of the initial stay-time threshold, and at the end of the work and recovery components of each work-rest cycle.
Environmental Symptoms Questionnaire-IV (ESQ-IV) total symptom score
Symptoms associated with heat exposure will be assessed using the Environmental Symptoms Questionnaire-IV (ESQ-IV). Responses will be combined to generate a total symptom score, with higher scores indicating greater environmental symptom burden.
Time frame: Assessed at baseline and following completion of each experimental trial.
Profile of Mood States-40 (POMS-40) total mood disturbance score
Mood state will be assessed using the abbreviated 40-item Profile of Mood States questionnaire (POMS-40). Responses will be used to calculate a total mood disturbance score, with higher scores indicating greater overall mood disturbance.
Time frame: Assessed at baseline and following completion of each experimental trial.
Changes in plasma volume
Change in plasma volume from baseline values calculated from duplicate measurements of hemoglobin and hematocrit at the start and end of each exposure using the technique by Dill and Costill.
Time frame: Assessed as baseline, and following each 240-minute morning and afternoon work period.
Started Oct 2026 (actual). Primary completion is estimated for Jun 2027, 8 months after the start.
Of 46 non-industry interventional studies with no phase under Body Temperature Changes, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 21. This study's planned 8 months is above that.
Counting every sponsor, half of 46 studies reached it within 5 months; a quarter within 3 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.